<DOC>
	<DOCNO>NCT02491320</DOCNO>
	<brief_summary>This study protocol multicenter , randomize , control trial . In protocol , present randomize controlled trial comparing acupuncture pretreatment follow letrozole vs letrozole alone polycystic ovary syndrome ( PCOS ) woman anovulatory infertility . The high prevalence insulin resistance ( IR ) woman PCOS woman consider one major pathophysiological change PCOS , lead anovulatiory infertility . A study show electro-acupuncture could significantly improve insulin sensitivity . The effect acupuncture pretreatment anovulatory PCOS woman follow ovulation induction investigate . A total 384 patient enrol study randomize one two group . The treatment group : 16 week acupuncture pretreatment follow 4 cycle letrozole control group : 4 cycle letrozole alone . The primary outcome live birth rate . We postulate acupuncture pretreatment follow letrozole result higher live birth rate compare letrozole alone .</brief_summary>
	<brief_title>The Clinical Trial Acupuncture Pre-treatment PCOS</brief_title>
	<detailed_description>1 . Study content 1.1 Study design This multi-centered , randomize , clinical trial . 1.2 Subject selection exclusion Initially , 384 PCOS woman anovulatory infertility recruit four hospital mainland China : Department Traditional Chinese Medicine first affiliate hospital Guangzhou Medical University , Department Gynecology Xuzhou maternity &amp; child health hospital , Department Reproduction Dalian Municipal Women Children 's Medical Center , Department Traditional Chinese Medicine Hexian memorial affiliate hospital Southern Medical University meet inclusion criterion exclusion criterion . Eligible subject approach sign consent form detailed explanation counseling . Recruited subject randomize one two group : Treatment group : 16 week acupuncture pre-treatment follow LE Control group : LE alone 1.3 Screening visit 1.3.1 Obtain sign informed consent 1.3.2 Complete physical examination Perform complete physical examination include height , weight , hip waist measurement . Height weight record near 0.1 cm 0.1 kg respectively . Waist hip circumference record near 1 cm . And assessment hirsutism Ferriamn Gallwey score ( FG ) , acne standard acne lesion count , pelvic exam Pap smear TCT . 1.3.3 Perform transvaginal ultrasound uterus ovary 1 . Uterus , include uterine dimension , endometrial thickness echo type , uterine abnormality , presence size leiomyoma obtain transvaginal ultrasound . 2 . Ovaries , include ovarian size three dimension , size large ovarian follicle/cyst size every follicle mean diameter great 10 mm , total antral follicle ( small follicle mean diameter &lt; 10 mm ) count ovary obtain transvaginal ultrasound . 1.3.4 Check urine pregnancy test 1.3.5 Laboratory Examination 1 . Serum level sex hormone steroid include blood follicle-stimulating hormone ( FSH ) , luteinizing hormone ( LH ) , estrogen ( E2 ) , prolactin ( PRL ) T , free testosterone , sex hormone bind globulin ( SHBG ) , thyroid stimulate hormone ( TSH ) evaluate second day spontaneous period withdrawal bleeding . 2 . Fasting blood take determine examination metabolic safety profile , include fast blood glucose , insulin , C-peptide , HbA1c , triglyceride , total cholesterol , high density lipoprotein ( HDL-C ) , low density lipoprotein ( LDL-C ) , CBC , Renal , Liver Profile . 3 . The oral glucose tolerance test ( OGTT ) 75 g glucose perform subject overnight fast . Blood sample obtain measure plasma glucose serum insulin 0 , 60 , 120 min OGTT . 1.3.6 Complete questionnaire Quality life assess short form 36 ( SF-36 ) , Chinese Quality Life ( ChiQOL ) , sleep questionnaire Polycystic Ovary Syndrome Questionnaire ( PCOS-QOL ) . Investigators also assess symptom anxiety depression Zung SAS Zung SDS questionnaire . And complete quantization table traditional Chinese medicine ( TCM ) syndromes PCOS . 1.3.7 Exclusion infertility factor couple The semen analysis husband tubal patency patient assess . 1.3.8 Preconception counsel Complete questionnaire risk factor genetic disorder , TORCH screening ( Toxoplasmosis , Rubella , Cytomegalo Virus , Herpes Virus ) HIV screening , folic acid prescription . 1.3.9 Progestin withdrawal Provide progestin prescription induce withdrawal bleed , instruction begin medication eligibility determine . 1.4 Baseline visit 1.4.1 Distribute home pregnancy test 1.4.2 Distribute folate 1.4.3 Distribute intercourse menstrual journal log 1.4.4 Take blood sample repository DNA Collect 20ml blood , distribute store 10ml blood serum separation . Other 10ml blood determination DNA . 1.5 Intervention arm Eligible patient randomize one two arm : Treatment group : i.e . 16 week acupuncture pretreatment follow LE . Acupuncture treatment start day 3-5 spontaneous period withdrawal bleed follow progestin . All subject request use contraception 16 week acupuncture pretreatment . They receive acupuncture treatment three time week . Each treatment session last 30 minute separate interval 1-3 day , maximum 48 treatment session 16 week . After 16 week acupuncture treatment , LE start day 2-3 spontaneous period withdrawal bleed progestin administration . The subject instruct intercourse regular basis cycle . Control group : i.e . LE alone . LE start day 3-5 spontaneous period withdrawal bleed follow progestin . The subject instruct intercourse regular basis cycle . 1.5.1 Acupuncture protocol Investigators base rationale acupuncture protocols Western Medical theory study protocol follow CONSORT STRICTA recommendation detail description treatment include number needle use , needle stimulate ( manual , electrical ) , frequency session , length treatment period . Investigators use fixed acupuncture protocol . Disposable , single-use , sterilize needle make stainless steel , 0.25 x 30 mm 0.30 x 40/50 mm ( Hwoto , Suzhou Medical Appliance Fact . 215005 Suzhou , China ) insert depth 15-35 mm segmental acupuncture point locate abdominal leg muscle innervation correspond ovary . Two set acupuncture point alternate every second treatment . The first set consist conception vessel ( CV ) 3 , CV 12 , stomach ( ST ) 29 bilaterally muscle knee , ST 34 , ST 33 bilaterally knee , spleen ( SP ) 6 ST 36 . Needles also place extra segmental acupuncture point innervate ovary large intestine ( LI ) 4 bilaterally . In total 14 needle place stimulate manually rotate needle evoke needle sensation ( de qi ) insert . The following point connect electrical stimulator ( Export Abteilung , Schwa-Medico GmbH , Wetzlarer Str . 41-43 ; 35630 Ehringshausen ) : CV 3 CV 12 , ST 29 bilateral , ST34 ST 33 bilateral . Stimulation give low-frequency EA 2Hz , 0.3 m pulse length intensity adjust produce local muscle contraction without pain discomfort . Needles connect electrical stimulator manually stimulate evoke needle sensation every 10 min , total 4 time . The second set consist 14 needle place segmental abdominal point stimulate electrically : ST 27 bilaterally , CV6 connect CV10 ; leg point : SP10 connect non-acupuncture point locate 6 cun proximal patella medial border ( electrical stimulation ) , SP 6 liver ( LR ) 3 bilaterally ( manual stimulation ) . Extra segmental point pericardium ( PC ) 6 bilaterally ( manual stimulation ) . 1.5.2 Needle insertion technique Needle insertion gentle . Tighten skin press around area needle insertion gently insert needle . Do n't quickly , gentle . 1.5.3 Needles stimulation Needles single use . Needle size : 0.25x30 mm 0.30 x 40 0.30 x 50 mm . Select needle length respect patient BMI . If patient low BMI thin use 0.25 x 30 mm needle . If patient overweight , use 0.30 x 40 mm needle . Obese patient , use needle size 0.30 x 50 75 mm . Depth insertion may vary patient patient . They place depth deep enough reach muscle/fibrous tissue . When needle insert , stimulate needle gently de qi ( needle sensation reflect activation sensory afferent ) . As soon de qi reach , make sure needle n't hurt cause pain discomfort . Attach electrodes accord protocol . Turn stimulator ( program 10 ) increase intensity . Instructions patient : `` As high possible pain discomfort '' . Do n't start intensive stimulation . After 10 minute , stimulate needle without electricity ask intensity electrical stimulation ok , increased/decreased . Repeat 20 minute 30 minute . Turn stimulator release patient . 1.5.4 Acupuncture treatment 1 . Record time day acupuncturist name patient receive acupuncture . 2 . Note intensity stimulation ( mA ) . It may vary different electrode . Note range e.g . 1.2 - 3.0 mA . 3 . Note event may affect treatment ( positive negative ) . 4 . Note concomitant medication . 5 . Collect menstrual intercourse journal log end every cycle . 6 . Check urine pregnancy test acupuncture treatment . If pregnancy test positive , acupuncture treatment perform . 1.5.5 Letrozole After 16 week acupuncture pretreatment , patient intervention group patient control group receive LE ( Femara , Novartis Pharmaceuticals ) , start 2.5mg daily day 2-3 5 day withdrawal bleed . Participants treat 4 cycle . If patient pregnant , treatment stop . If evidence ovulation ( i.e . serum progesterone level 3th week high 3 ng/mL ) delay one week , dose maintain . In patient ovulatory response , dose increase LE 5mg day five day LE 7.5 mg per day five day reach . The LE dose continued next cycle patient show ovulate . And maximum daily dose LE 7.5 mg ( three pill ) daily . 1.6 Monitoring examination treatment And subject instruct intercourse regular basis entire study period . The optimal frequency every 2-3 day . Urine pregnancy test check acupuncture treatment ovulation . And serum progesterone level test check local lab day 3th week first cycle every week last three cycle . The transvaginal ultrasound exam take place anticipate luteal phase cycle , initially schedule 3 week initiation medication , window 4 day either side day ( i.e . Day 17-25 , assume Day 3 medication start , Day 19-27 , assume Day 5 start ) . The ultrasound include endometrial thickness echogenicity , well number , size , echogenic characteristic follicles/cysts ovary ( include antral follicle count ) . Investigators decide whether patient ovulation respond base result serum progesterone level transvaginal ultrasound . There three possible scenario : ovulation , ovulation delay non-ovulation . 1 ) Ovulation , i.e . serum progesterone level 3th week high 3 ng/mL , ultrasound may provide presumptive evidence ovulation . Check urine pregnancy test exclude pregnancy start LE tablet day 3-5 menstruation , dose maintain ; 2 ) Ovulation delay , P &lt; 3 ng/mL , ultrasound show evidence follicular development , ( i.e . follicle mean diameter ≥12 mm ) . Investigators wait one week continue acupuncture treatment . Check urine pregnancy test exclude pregnancy start LE tablet day 3-5 menstruation , dose maintain ; 3 ) Non-ovulation , P &lt; 3 ng/mL , ultrasound find follicle mean diameter ≥12 mm . The patient also receive LE tablet day 3-5 cycle , instructed increase study drug one tablet per day five day . Every menstruation detail record , include date , volume duration menstruation . 1.7 End pre-treatment visit 1 ) Repeat OGTT . 2 ) Collect menstrual journal log . 1.8 Pregnancy visit ( conception ) 1 . Complete adverse event query . 2 . Take blood serum quantitative hCG level ultrasound observe gestational sac ( 1500-2000IU/ml ) . 3 . Perform transvaginal ultrasound number gestational sac , location , dimension , presence size fetal part , documentation visualization fetal heart motion , documentation pregnancy related abnormality hCG level clinical manifestation appear pregnancy . 1.9 End treatment visit 1 . Perform physical examination , include vital sign , height , weight , hip waist measurement well repeat hirsutism acne assessment end treatment pregnancy . 2 . Repeat serum level sex hormone steroid metabolic profile . 3 . Repeat OGTT . 4 . Collect 20ml blood , distribute store 10ml blood serum separation . Other 10ml blood determination DNA . 5 . Repeat QOL , sleeping , anxiety/depression questionnaire , quantization table TCM . 6 . Collect menstrual intercourse journal log . 7 . Record adverse event concomitant medication . 8 . Arrange follow subject conceive obtain release record pregnancy neonatal record . 1.10 Follow visit For woman ongoing pregnancy , arrangement make follow outcome pregnancy end first trimester also delivery termination gestation . All pregnancy ( include multiple ) follow monitor weight , glucose tolerance , blood pressure fetal growth determine abortion rate , complication rate pregnancy outcomes . The glucose tolerance test glucose screen test 75 g glucose perform pregnancy 24-28 week pregnancy . Patients inform notify study personnel outcome pregnancy investigator obtain release record form treat physician obtain copy relevant medical record . Delivery record mother newborn request determine birth weight , length gestation , prenatal complication mother neonatal complication infant . Phone contact initiate patient contact study personnel six week beyond original estimated date confinement . And investigator collect pregnancy outcome data . Investigators track outcomes subject positive serum pregnancy screen course study . Investigators record biochemical pregnancy ( define positive serum pregnancy screen without ultrasonically detect pregnancy ) , ectopic pregnancy , intrauterine pregnancy loss 20 week include missed abortion , spontaneous abortion , elective abortion , fetal demise , stillbirth . Investigators review pregnancy birth record mother fetus establish neonatal morbidity mortality presence fetal anomaly . Investigators extract record concomitant medical obstetrical condition , exposure information medical product use , include prescription product , over-the-counter ( OTC ) product , dietary supplement , vaccine , insertable implantable medical device . Investigators file individual case report congenital anomaly , consider serious adverse event . 1.11 Safety analysis Adverse event categorized percentage patient experience adverse event serious adverse event treatment period document . Chi-square test perform examine difference proportion total category adverse event . 1.12 Statistical test One sample Kolmogorov-Smirnov test use test normal distribution continuous variable . Continuous variable show mean ± standard deviation normally distribute median interquartile range normally distribute . Statistical comparison carry accord intention treat Student 's t-test , Mann-Whitney U-test , Wilcoxon sign rank test continuous variable χ2 test categorical variable appropriate . All statistical analysis data perform use SPSS program version 21.0 ( SPSS Inc. , Chicago , IL , USA ) , P-value &lt; 0.05 consider statistically significant .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Polycystic Ovary Syndrome</mesh_term>
	<mesh_term>Polystyrene sulfonic acid</mesh_term>
	<mesh_term>Letrozole</mesh_term>
	<mesh_term>Progestins</mesh_term>
	<criteria>1 . Women age 20 40 year . 2 . Confirmed diagnosis PCOS accord 2003 modify Rotterdam criterion 3 . According World Health Organization standard ( 2010 ) , semen analysis husband must meet ① ② . ①sperm concentration ≥15*106/ml total motility ≥40 % . ② Total motile sperm count ≥9 million , i.e . semen volume*sperm density*percentage motile sperm ≥9 million . 4 . At least one patent tube show hysterosalpingogram diagnostic laparoscopy . The result valid 3 year patient history abortion pelvic operation . 1 ) Exclusion endocrine disorder : Patients hyperprolactinemia ( define two prolactin level least one week apart 25 ng/mL great determine local normative value ) . The goal eliminate patient document hyperprolactinemia decrease heterogeneity PCOS population . These patient may candidate ovulation induction alternate regimen ( dopamine agonist ) . A normal level within last year treatment adequate entry . Patients FSH level &gt; 15 mIU/mL . A normal level within last year adequate entry . Patients uncorrected thyroid disease ( define TSH &lt; 0.2 mIU/mL &gt; 5.5 mIU/mL ) . A normal level within last year adequate entry . Patientsdiagnosed Type I Type II diabetes poorly control ( define Hb A1c level &gt; 7.0 % ) , patient receive antidiabetic medication insulin , thiazolidinediones , acarbose , sulfonylurea likely confound effect study medication ; Patients currently receive metformin XR ( extended release ) diagnosis Type I Type II diabetes PCOS also specifically exclude . ⑤Patients suspect Cushing 's syndrome . 2 ) Use hormonal medication include Chinese Herbal prescription may affect outcome least past 2 month . 3 ) Acupuncture last 2 month . 4 ) Pregnancy within past 6 week . 5 ) Within 6 week postabortion postpartum . 6 ) Breastfeeding within last 6 month . 7 ) Not willing give write consent study . 8 ) Additional exclusion criterion 1 . Patients suspect adrenal ovarian tumor secrete androgen . 2 . Couples previous sterilization procedure ( vasectomy , tubal ligation ) reverse . The prior procedure may affect study outcome , patient reverse sterilization procedure PCOS rare enough exclusion adversely affect recruitment . 3 . Subjects undergone bariatric surgery procedure recent past ( &lt; 12 month ) period acute weight loss advise pregnancy bariatric surgeon . 4 . Patients untreated poorly control hypertension define systolic blood pressure 160 mm Hg diastolic 100 mm Hg obtain two measure obtain least 60 minute apart . 5 . Patients know congenital adrenal hyperplasia . 6 . Patients oral contraceptive , depot progestin , hormonal implant ( include Implanon ) . A two month washout period require prior screening patient agent . Longer washouts may necessary certain depot contraceptive form implant , especially implant still place . A onemonth washout require patient oral cyclic progestin . 7 . Patients liver disease define AST ALT &gt; 2 time normal totalbilirubin &gt; 2.5 mg/dL . Patients renal disease define BUN &gt; 30 mg/dL serum creatinine &gt; 1.4 mg/dL . 8 . Patients significant anemia ( Hemoglobin &lt; 10 g/dL ) . 9 . Patients history deep venous thrombosis , pulmonary embolus , cerebrovascular accident . 10 . Patients know heart disease likely exacerbated pregnancy . 11 . Patients history , suspect cervical carcinoma , endometrial carcinoma , breast carcinoma . A normal Pap smear TCT result require woman 21 . 12 . Patients current history alcohol abuse . Alcohol abuse define &gt; 14 drinks/week binge drinking . 13 . Patients enrol simultaneously investigative study require medication , proscribe study medication , limit intercourse , otherwise prevent compliance protocol . 14 . Patients anticipate take longer one month break protocol enrol . 15 . Patients take medication know affect reproductive function metabolism . These medication include oral contraceptive , GnRH agonists antagonist , antiandrogens , gonadotropin , antiobesity drug , Chinese herbal formula , antidiabetic drug metformin thiazolidinediones , somatostatin , diazoxide , ACE inhibitor , calcium channel blocker . The washout period medication two month .</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>polycystic ovary syndrome</keyword>
	<keyword>acupuncture</keyword>
	<keyword>pre-treatment</keyword>
	<keyword>Letrozole</keyword>
	<keyword>Live Birth</keyword>
</DOC>